Bullboard Post History

by DJDawg

Order by:

V.TLT	Dr. Black article on Phase 2 Trial of Atezolizumab In the discussion they have a nice summary of the other drugs in the... August 23, 2023
V.TLT	RE:RE:RE:RE:RE:RE:We are totally blowing Keytruda out of the water To add to Enrique's post re Atezolizumab (more famously called Tecentriq)... August 22, 2023
V.TLT	swing back between hope and frustration I swing back and forth on TLT so much. Some things give me hope and other... August 20, 2023
V.TLT	RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:share activity Recall that the phase 1b data was 66% CR and kept the CR. That kind of... August 18, 2023
V.TLT	RE:RE:RE:RE:RE:RE:RE:RE:RE:share activity Meant 3-4m as 3-4 months runway. August 18, 2023
V.TLT	RE:RE:RE:RE:RE:RE:RE:share activity The last PP ending June 30 bought them 3-4 m of cash. So that means end of... August 18, 2023
V.TLT	RE:RE:RE:RE:RE:RE:share activity That makes sense and explains the share price patterns. Just weird doing it... August 18, 2023
V.TLT	RE:RE:RE:RE:RE:share activity agreed. It is strange to do another PP so soon. I just don't get the... August 18, 2023
V.TLT	RE:RE:RE:share activity Can you email RDW with your suggestion :) August 17, 2023
V.TLT	share activity I've always found it strange how this oscillates between 0.23 and 0.3... August 17, 2023
V.TLT	RE:RE:RE:1.3B$US for a 2030 drug RDW doesn't seem old to me. CEOs all seem to be older folks. I think... August 15, 2023
V.TLT	RE:RE:RE:RE:RE:RE:RE:Photodynamic Therapy Market to grow at a CAGR of 8.22% In all fairness to you stepson, I work in a medical clinic and if someone... August 9, 2023
V.TLT	RE:RE:RE:RE:RE:Photodynamic Therapy Market to grow at a CAGR of 8.22% No one new has heard of it yet. Hence no new buyers. Those of us who know it... August 8, 2023
V.TLT	RE:RE:Photodynamic Therapy Market to grow at a CAGR of 8.22% It is the most recent approved therapy for NMIBC. Approved Dec 2022 but not... August 8, 2023
V.TLT	RE:June 27, 2022 I do agree. There is a May 2023 corp presentation on the website. But you don... August 7, 2023
V.TLT	FDA Criteria ( with confidence intervals) The FDA panel from way back indicated support for a drug that could achieve ... August 6, 2023
V.TLT	Adstiladrin (data post) Because of Wildbird's recent post on Adstiladrin I went back to find the... August 6, 2023
V.TLT	RE:RE:RE:RE:Volume Since we have nothing else to do, I'll speculate. If he said it "... August 3, 2023
V.TLT	status update (no, nothing new) I continue to keep an eye on google trends and other sources to see if any... July 25, 2023
V.TLT	RE:RE:RE:RE:RE:RE:3M chart = higher highs, higher lows I think you may be misreading that. Can you show where you got that from? I... July 20, 2023

Become a member today, It's free!

Bullboard Post History

by DJDawg

Dr. Black article on Phase 2 Trial of Atezolizumab

RE:RE:RE:RE:RE:RE:We are totally blowing Keytruda out of the water

swing back between hope and frustration

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:share activity

RE:RE:RE:RE:RE:RE:RE:RE:RE:share activity

RE:RE:RE:RE:RE:RE:RE:share activity

RE:RE:RE:RE:RE:RE:share activity

RE:RE:RE:RE:RE:share activity

RE:RE:RE:share activity

share activity

RE:RE:RE:1.3B$US for a 2030 drug

RE:RE:RE:RE:RE:RE:RE:Photodynamic Therapy Market to grow at a CAGR of 8.22%

RE:RE:RE:RE:RE:Photodynamic Therapy Market to grow at a CAGR of 8.22%

RE:RE:Photodynamic Therapy Market to grow at a CAGR of 8.22%

RE:June 27, 2022

FDA Criteria ( with confidence intervals)

Adstiladrin (data post)

RE:RE:RE:RE:Volume

status update (no, nothing new)

RE:RE:RE:RE:RE:RE:3M chart = higher highs, higher lows

Featured Company

Eminent Gold Corp. V.EMNT

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard Post History

by DJDawg

Featured Company